Lunai Bioworks

Decoding life. Delivering cures.

[Lunai Bioworks @lunaibioworks]

Hello! 👋 We’re Lunai Bioworks. Decoding life. Discovering cures. Our AI-powered phenomics platform captures disease in motion, decoding biology at scale to bring clarity to complexity.

[Lunai Bioworks @lunaibioworks]

Learn more about Lunai Bioworks: https://t.co/FParhUsIrt

[Lunai Bioworks @lunaibioworks]

Lunai Bioworks will be at the BIO International Convention in San Diego on June 22-25, and we’re looking to connect with potential partners in biotech and drug discovery. #BIO2026 #Biotech #Partnerships

[Lunai Bioworks @lunaibioworks]

Attending BIO 2026? Reach out to Gabe Musso, CSO at BioSymetrics (a Lunai Bioworks company), through the BIO Partnering system.

[Lunai Bioworks @lunaibioworks]

Learn more about Lunai Bioworks: https://t.co/FParhUsIrt

[Lunai Bioworks @lunaibioworks]

We at Lunai Bioworks support this week’s open letter on nucleic acid synthesis screening and record-keeping. It shows broad alignment around practical biosecurity safeguards, including the CEOs of @OpenAI, @AnthropicAI, and @MicrosoftAI. #Biosecurity #Biodefense #AIinBiology

[Lunai Bioworks @lunaibioworks]

We see our work as part of that broader effort, with Sentinel on prevention, Pathfinder and @biosymetrics on threat assessment, and Counteract on medical countermeasure development.

[BioSymetrics @biosymetrics]

BioSymetrics (a @lunaibioworks company) and BrainStorm Therapeutics have launched a strategic collaboration, backed by the LouLou Foundation, to discover and validate new therapeutic targets for neurological diseases. #Neurology #PrecisionMedicine #DrugDiscovery

[BioSymetrics @biosymetrics]

At BioSymetrics, the Phenograph is part of @lunaibioworks' platform for connecting prediction to proof. Together with Augusta and zebrafish-based in vivo modeling, it links translation and validation in one workflow. #DrugDiscovery #ArtificialIntelligence #TranslationalScience

[Lunai Bioworks @lunaibioworks]

Read the press release: https://t.co/9IgndMTCk5. Learn more at https://t.co/FParhUsIrt.

[Lunai Bioworks @lunaibioworks]

Lunai Bioworks has completed and expanded our previously announced $20M CNS-focused transaction through the NeuroBridge IP acquisition, adding complementary brain-delivery capabilities to our CNS platform. #CNS #DrugDelivery #Neuroscience

[Lunai Bioworks @lunaibioworks]

Together, these capabilities are intended to support multi-agent strategies, meaning combinations of therapeutic agents with different mechanisms of action, and more targeted development with Augusta.

[BioSymetrics @biosymetrics]

BioSymetrics (a @lunaibioworks company) signed a non-binding Letter of Intent with Geneial to build trial-ready cohorts from patient-led data, starting in select rare neurodevelopmental disorders. #RareDisease #ClinicalTrials #PrecisionMedicine

[BioSymetrics @biosymetrics]

BioSymetrics (a @lunaibioworks company) is at the AWS Life Sciences Symposium in NYC today (April 14) at the Javits Center. If you’re here too, let’s connect. #LifeSciences #DrugDiscovery #AWS

[BioSymetrics @biosymetrics]

BioSymetrics (a @lunaibioworks company) is heading to the AWS Life Sciences Symposium in NYC on Tuesday, April 14 at the Javits Center. If you’re attending, let’s connect. #LifeSciences #DrugDiscovery #AWS